Izabela Tworowska, RadioMedix CSO, selected as Semi-Finalists of 2021 Women’s Venture Competition!
Posted by RadioMedix . on
The AIM-HI Accelerator Fund just announced 10 semi-finalists for the 2021 Women’s Venture Competition! These oncology companies have been selected from among an exceptional pool of applications submitted globally by women scientist-entrepreneurs. Decision making was led by a selection committee comprised of world-class key opinion leaders, life sciences industry experts, investors, and entrepreneurs.
The Women’s Venture Competition is a first-of-its-kind program that provides funding, coaching, and networking opportunities to women-led oncology start-ups. The chosen semi-finalists are advancing to a virtual competition being conducted on August 2, 2021.
The winning company, to be determined by a word-class judging committee, will receive a total of $1 million in investment from AIM-HI and co-investors. The investment will serve as early seed money for proof of concept and proof of value on the path to clinical trials, and eventually, to new effective cancer treatments that could save patients’ lives.
Please join us and support the Women’s Venture Competition! Donate today, and your gifts will help us launch more women leaders who are creating life-saving oncology innovations!